How to build a due diligence findings and risk tracker for Corporate Restructuring Transactions

Build a company-side restructuring findings tracker around the numbered transaction steps, not merely the data-room folders. Link each finding to an affected entity, proposed transfer or merger, source document, business consequence, and accountable decision-maker. Separate verified facts from missing evidence and legal assessments, then record the mitigation and evidence needed to resolve the issue. The deliverable is a source-backed decision record showing which steps are ready, which need further analysis, and which remain dependent on approvals, consents, releases, or alternative arrangements.

When to use this workflow

Use this workflow when company counsel receives a proposed restructuring step plan and needs to identify execution risks before the structure becomes fixed. It suits internal reorganizations, out-of-court mergers, asset transfers, and corporate separations involving multiple entities, shared contracts, financing obligations, or retained liabilities.

The tracker explains why an issue matters and what resolves it. It links to—but does not replace—the step plan, consent register, document index, or closing checklist.

This is a general US legal-workflow guide, with Delaware corporate-law illustrations and a federal procurement overlay. Entity form, incorporation jurisdiction, governing documents, contract language, and transaction facts determine the applicable analysis. Assign tax, securities, antitrust, bankruptcy, employment, and non-US issues to appropriate specialists rather than treating this tracker as their substantive review.

What you need

Start with the current numbered step plan and before-and-after entity charts. Confirm legal names, ownership, jurisdictions, survivor identities, asset destinations, and sequencing with the company team.

Collect these supporting materials:

• Corporate records: certificates, bylaws, ownership records, proposed approvals, and existing authorization evidence.
• Transfer perimeter: asset and liability schedules, employee and IP allocations, intercompany arrangements, and retained-business dependencies.
• Contract families: executed agreements, amendments, schedules, incorporated terms, guarantees, financing documents, lien information, and relevant permits.
• Execution documents: restructuring drafts, ancillary agreements, consent correspondence, release requests, and proposed interim arrangements.
• Business inputs: operational criticality, custodians, acceptable alternatives, and the people authorized to accept residual exposure.

Create a document index with stable IDs, source locations, execution status, amendments, confidentiality restrictions, and reviewers. Label an unavailable document “not supplied,” not “does not exist.” Give each outstanding request a business custodian and explain which restructuring decision it supports.

Use the template

The companion template is Corporate Restructuring Transactions — Diligence findings tracker. Copy this table into your working document or spreadsheet. Use one row per independently resolvable decision.

Keep issue IDs stable when the step plan changes. Identify both the current holder and intended recipient or survivor. Cite the document ID, section or page, and relevant version; a folder link alone is insufficient.

Label verified facts, missing evidence, and counsel assessments within the cells. State severity and business consequence separately from confidence in the evidence. Link dependencies by issue ID.

Distinguish the person performing the work from the person authorized to approve the outcome. Separate contractual triggers from internal target dates. Use the final column for both current status and acceptable closure evidence. Link longer analysis rather than removing qualifications to fit a cell.

Step by step

1. Anchor the review to the restructuring mechanics

Assign a step number to each merger, asset movement, equity transfer, guarantee release, and shared-contract separation. Reconcile the step plan with the entity charts and allocation schedules before reviewing restrictions.

A contract remaining with a survivor presents different questions from one moving through an asset transfer. Delaware’s § 259(a) provides for statutory vesting of property and attachment of liabilities in a merger, while preserving creditor rights and liens. Counsel must separately assess contract wording, permits, and other applicable law for consent or notice requirements. See DGCL § 259(a).

Record: the step, affected entities, current holder, intended destination, and any unresolved discrepancy.

2. Establish source completeness before drawing conclusions

Group each agreement with its amendments, schedules, guarantees, and incorporated terms. Compare its parties and covered operations with the restructuring perimeter, including operations remaining with the company.

Review assignment, merger, operation-of-law, change-of-control, termination, and notice wording separately. Check term, exclusivity, pricing, and guarantees where they affect separation. If a missing schedule defines the licensed business, do not infer coverage from the agreement title or business team’s description.

Record: controlling citations, execution status, missing materials, responsible custodian, and whether the gap prevents analysis or limits confidence. Keep the gap open until evidence arrives or the team documents why it no longer matters.

3. Write findings that distinguish evidence from assessment

Draft each finding in three parts: what the source establishes, what remains unknown, and why the proposed step matters. Avoid “nonassignable” or “consent required” when the operative trigger remains unresolved.

For example, state that a clause restricts assignment, the proposed mechanism is a merger, and counsel must determine whether the restriction reaches that mechanism. Identify the potential business interruption without declaring an unsupported breach.

Record: an accurate paraphrase or short quotation, explicit uncertainty, counsel’s assessment, and the consequence of leaving the issue unresolved. Link related findings rather than combining different resolution paths in one row.

4. Separate approval, consent, novation, and release questions

Do not group all permissions under “approval.” For Delaware domestic corporate mergers under § 251, subsection (b) requires board approval and an advisability determination; subsection (c) supplies the ordinary stockholder-adoption and filing route. Test exceptions and alternative routes before assigning tasks. See DGCL § 251(b)–(c).

For asset dispositions, § 271(a) addresses board action and stockholder authorization for all-or-substantially-all transactions. Subsection (c) generally removes the stockholder-resolution requirement for transfers to a wholly owned and controlled subsidiary, directly or indirectly, unless the certificate provides otherwise. Assess the threshold, charter, and relevant exceptions, including § 272. See DGCL §§ 271–272.

For federal contracts, FAR 42.1204 distinguishes specified asset transfers from qualifying stock purchases that leave the contractor legally unchanged, controlling the assets, and performing the contract. Its novation submission provisions apply to that workstream, not every restructuring. See FAR 42.1204(a)–(b), (e)–(g).

Record: each distinct permission or release, its basis, reviewer, and required evidence.

5. Prioritize by execution consequence and retained exposure

Define an internal severity scale. A critical finding might prevent the intended sequence or threaten an essential operating contract. A high-priority finding might leave Holdings exposed under a guarantee after the business moves. Lower-priority issues still need owners and closure criteria.

Consider timing alongside impact: an issue affecting the first transfer may need attention before a larger issue relevant only to a later optional step. Keep severity separate from evidentiary confidence. A missing document can justify escalation without establishing a prohibition.

Record: severity, rationale, affected business function, retained exposure, and the decision that cannot yet be made. Reassess priority when the step plan or business assumptions change.

6. Define a mitigation and decision path

State the company’s preferred outcome and a workable fallback. Options may include consent, resequencing, narrowing an allocation, obtaining a release, or evaluating an interim arrangement. Test each against the documents and applicable law before treating it as available.

Shared contracts require particular care. As a negotiated drafting example, § 2.8 of the 3M–Solventum separation agreement addresses partial assignment or amendment and permissible alternatives, subject to limitations. It is not authority to split another contract or override counterparty rights. See the executed separation agreement, § 2.8.

Record: preferred mitigation, fallback, dependencies, owner, decision-maker, and escalation target. Identify changes to economics or sequencing. If resolution depends on a closing condition, distinguish satisfaction evidence from any proposed waiver and verify the relevant authority.

7. Close findings against evidence and preserve unresolved decisions

Revisit findings at each material step-plan revision. Reopen affected rows when the destination entity, mechanism, perimeter, or governing draft changes. Preserve the earlier conclusion and reason for revision.

Do not close a consent issue because a request was sent or an approval issue because minutes were drafted. Check completed evidence against the actual requirement. Distinguish risk eliminated from residual exposure accepted; management acceptance does not substitute for a legally required approval.

Record: closure evidence, reviewer, and review date—or the unresolved issue, authorized decision, and follow-up owner. Link continuing obligations to the post-closing record without deleting their diligence history.

Worked example

Fictional scenario: Alder Quay Holdings, Inc. plans to transfer its diagnostics business to wholly owned Alder Quay Diagnostics, Inc. in S2, then merge Alder Quay Services, Inc. into Holdings in S3. Holdings holds a shared software license and guarantees Services’ debt. Services holds a federal supply contract. All parties, documents, and provisions below are fictional.

The business team describes both steps as administrative. Counsel instead separates software rights, federal contracting continuity, and the guarantee that may remain after Services disappears.

F01 does not establish that Diagnostics lacks rights: the missing schedule prevents that conclusion. F02 makes sequencing provisional rather than treating statutory succession as the complete federal contracting analysis. F03 concerns S3, not S2, because the guaranteed debtor is Services; transferring the diagnostics business is not the identified trigger.

The team must now obtain evidence, assess sequencing, and decide whether any residual credit exposure is acceptable. None of the three findings can be closed merely because the restructuring documents are ready for signature.

Common mistakes

• Organizing only by document category. Link each finding to the specific movement or retained obligation, even when one financing document affects several steps.
• Treating common ownership as the answer. Analyze the actual transfer mechanism, contract wording, and approval route instead.
• Combining consent with release. Track permission to transfer and discharge of company exposure as separate outcomes with separate evidence.
• Calling missing evidence a violation. Describe the gap and consequence of uncertainty; reserve legal conclusions for supported analysis.
• Closing on a proposed workaround. Verify the arrangement’s legal basis, execution status, and remaining exposure before marking the finding resolved.

Final quality check

• Every material finding maps to the current step plan and correct entities.
• Source IDs resolve to reviewed versions with clause or page citations.
• Amendments and incorporated terms are reviewed or flagged as missing.
• Facts, uncertainties, and counsel assessments remain distinguishable.
• Severity reflects an identified execution consequence or retained exposure.
• Mitigations identify dependencies, owners, decision-makers, and closure evidence.
• Open issues are resolved or expressly assigned, with authorized decisions preserved.
• Applicable legal sources and effective-date provisions are checked for the transaction date.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its due diligence capabilities include bulk document classification to organize materials and prioritize human review. Contract review and tabular review support analysis across documents. The tracker remains the team’s work product: lawyers verify sources, assess restructuring consequences, and approve decisions. To discuss this company-side workflow, book a demo.

Frequently asked questions

Should every reviewed document create a finding?

No. Track review coverage in the document index. Create findings for actionable risks, material uncertainties, or decisions affecting the restructuring. Otherwise, routine records obscure readiness issues.

Can one issue cover several group entities?

Yes, if evidence, analysis, ownership, and resolution are shared. Split the issue when counterparties, transfer mechanisms, rights, or closure requirements differ. Keep linked IDs for related decisions.

How should unresolved shared contracts be tracked?

Identify the contracting entity, affected operations, proposed split, and missing permissions. Record interim arrangements separately, including their source basis and remaining exposure. Operational feasibility is not the same as documented permission.

When can a finding move to post-closing follow-up?

After counsel identifies a supported path for proceeding and the authorized decision-maker approves it. Preserve the obligation, contractual trigger, required evidence, and owner. Moving the row does not satisfy a condition or remove risk.

Sources

Check applicable effective-date provisions before transaction-specific reliance.

• Delaware Code, Title 8, §§ 251 and 259.
• Delaware Code, Title 8, §§ 271–272.
• FAR 42.1204, Applicability of novation agreements.
• 3M–Solventum Separation and Distribution Agreement, § 2.8, solely as a negotiated drafting example.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.